MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$80,403K
(-55.25%↓ Y/Y)
Net loss
-$80,403K
(-55.25%↓ Y/Y)
Loss from operations
-$52,555K
(1.00%↑ Y/Y)
Total other (expense)
income, net
-$27,848K
(-2247.11%↓ Y/Y)
Research and
collaboration revenue
$3,498K
(436.50%↑ Y/Y)
Interest income
$2,174K
(63.46%↑ Y/Y)
Total operating
expenses
$56,053K
(4.30%↑ Y/Y)
Change in fair value of
derivative tranche...
-$29,830K
Other expense
$192K
(481.82%↑ Y/Y)
Research and development
$38,202K
(-1.58%↓ Y/Y)
General and
administrative
$17,357K
(16.31%↑ Y/Y)
Impairment of right-of-use
asset
$494K
Back
Back
Income Statement
source: myfinsight.com
Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP)